Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PYXS is expected to report earnings to fall 75.05% to -32 cents per share on May 09
Q1'25
Est.
$-0.33
Q4'24
Missed
by $1.00
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.18
The last earnings report on March 19 showed earnings per share of -132 cents, missing the estimate of -31 cents. With 225.62K shares outstanding, the current market capitalization sits at 62.82M.